Diabetes and the abdominal aortic aneurysm.

OBJECTIVE The aim of this review is to delineate the association between abdominal aortic aneurysms (AAAs) and diabetes mellitus. Mechanisms for the underlying association are then discussed. METHODS A systematic review of the English-language literature using PubMed, EMBASE and Cochrane databases was undertaken up to September 2009. Studies reporting appropriate prevalence data were identified and a meta-analysis performed. RESULTS Eleven studies were identified. The prevalence of diabetes mellitus in studied patients with AAA ranged from 6% to 14%. The prevalence of diabetes in control patients without AAA ranged from 17% to 36%. Pooled analysis suggested a reduced rate of diabetes amongst people with AAA compared to those without (OR 0.65, 0.60-0.70, p<0.001). CONCLUSIONS Studies so far suggest a protective role for diabetes on the development of AAA. Further research is required to demarcate the underlying mechanisms for this possible association.

[1]  K. Jamrozik,et al.  Screening for abdominal aortic aneurysm: lessons from a population‐based study , 2000, The Medical journal of Australia.

[2]  J. Powell,et al.  Simvastatin attenuates the activity of matrix metalloprotease-9 in aneurysmal aortic tissue. , 2007, European journal of vascular and endovascular surgery : the official journal of the European Society for Vascular Surgery.

[3]  Jean-Baptiste Michel,et al.  Renewal of mural thrombus releases plasma markers and is involved in aortic abdominal aneurysm evolution. , 2006, The American journal of pathology.

[4]  S. Haffner,et al.  Effect of Rosiglitazone Treatment on Nontraditional Markers of Cardiovascular Disease in Patients With Type 2 Diabetes Mellitus , 2002, Circulation.

[5]  D. Aronson.  Cross-linking of glycated collagen in the pathogenesis of arterial and myocardial stiffening of aging and diabetes , 2003, Journal of hypertension.

[6]  Donald A Redelmeier,et al.  Angiotensin-converting enzyme inhibitors and aortic rupture: a population-based case-control study , 2006, The Lancet.

[7]  J. Michel,et al.  Involvement of the mural thrombus as a site of protease release and activation in human aortic aneurysms. , 2002, The American journal of pathology.

[8]  C. Pollock,et al.  High glucose increases growth and collagen synthesis in cultured human tubulointerstitial cells , 1999, Diabetic medicine : a journal of the British Diabetic Association.

[9]  K. Jamrozik,et al.  Negative association between infra-renal aortic diameter and glycaemia: the Health in Men Study. , 2007, European journal of vascular and endovascular surgery : the official journal of the European Society for Vascular Surgery.

[10]  Simon G. Thompson,et al.  Abdominal Aortic Aneurysm Expansion: Risk Factors and Time Intervals for Surveillance , 2004, Circulation.

[11]  J. Bronzwaer,et al.  Diastolic Stiffness of the Failing Diabetic Heart: Importance of Fibrosis, Advanced Glycation End Products, and Myocyte Resting Tension , 2008, Circulation.

[12]  B. Kelley,et al.  Suppression of experimental abdominal aortic aneurysms in the rat by treatment with angiotensin-converting enzyme inhibitors. , 2001, Journal of vascular surgery.

[13]  M. Engelgau,et al.  Diabetes trends in the U.S.: 1990-1998. , 2000, Diabetes care.

[14]  P. Delvenne,et al.  Activated forms of MMP2 and MMP9 in abdominal aortic aneurysms. , 1996, Journal of vascular surgery.

[15]  J. Reynolds,et al.  The Role of Plasmhogen Activators in the Regulation of Connective Tissue Metalloproteinases a , 1992 .

[16]  L. Pointon,et al.  Co-Morbidity in Patients with Abdominal Aortic Aneurysm , 1996, Journal of medical screening.

[17]  R. Gianrossi,et al.  Screening for abdominal aortic aneurysms and associated risk factors in a general population. , 1995, European journal of vascular and endovascular surgery : the official journal of the European Society for Vascular Surgery.

[18]  Biao Xu,et al.  Advanced Glycation End Products Inhibit Production and Activity of Matrix Metalloproteinase-2 in Human Umbilical Vein Endothelial Cells , 2007, The Journal of international medical research.

[19]  P. Norman,et al.  Prevalence of abdominal aortic aneurysms in men with diabetes , 1997, The Medical journal of Australia.

[20]  J. Golledge,et al.  Matrix Biology of Abdominal Aortic Aneurysms in Diabetes: Mechanisms Underlying the Negative Association , 2007, Connective tissue research.

[21]  P. Grant,et al.  The influence of type 2 diabetes on fibrin structure and function , 2005, Diabetologia.

[22]  S. Takebayashi,et al.  Effects of advanced glycation end products on the proliferation and fibronectin production of smooth muscle cells. , 2000, Journal of atherosclerosis and thrombosis.

[23]  K Lachowycz,et al.  Diabetes prevalence in England, 2001—estimates from an epidemiological model , 2006, Diabetic medicine : a journal of the British Diabetic Association.

[24]  S. Haffner,et al.  Relative contribution of insulin and its precursors to fibrinogen and PAI-1 in a large population with different states of glucose tolerance. The Insulin Resistance Atherosclerosis Study (IRAS). , 1999, Arteriosclerosis, thrombosis, and vascular biology.

[25]  Timothy C Greiner,et al.  Matrix metalloproteinases 2 and 9 work in concert to produce aortic aneurysms. , 2002, The Journal of clinical investigation.

[26]  W. Lamorte,et al.  Racial differences in the incidence of femoral bypass and abdominal aortic aneurysmectomy in Massachusetts: relationship to cardiovascular risk factors. , 1995, Journal of vascular surgery.

[27]  J. Blanchard,et al.  Epidemiology of abdominal aortic aneurysms. , 1999, Epidemiologic reviews.

[28]  S. Wild,et al.  Global prevalence of diabetes: estimates for the year 2000 and projections for 2030. , 2004, Diabetes care.

[29]  É. Allaire,et al.  Prevention of aneurysm development and rupture by local overexpression of plasminogen activator inhibitor-1. , 1998, Circulation.

[30]  P. Karanjia,et al.  Coexistence of Abdominal Aortic Aneurysm in Patients With Carotid Stenosis , 1994, Stroke.

[31]  J. Michel,et al.  Topology of the fibrinolytic system within the mural thrombus of human abdominal aortic aneurysms , 2007, The Journal of pathology.

[32]  J. Golledge,et al.  Reduced expansion rate of abdominal aortic aneurysms in patients with diabetes may be related to aberrant monocyte-matrix interactions. , 2008, European heart journal.

[33]  M. Thompson,et al.  Ubiquitous Elevation of Matrix Metalloproteinase-2 Expression in the Vasculature of Patients With Abdominal Aneurysms , 2001, Circulation.

[34]  R. Muraro,et al.  The Receptor RAGE as a Progression Factor Amplifying Arachidonate-Dependent Inflammatory and Proteolytic Response in Human Atherosclerotic Plaques: Role of Glycemic Control , 2003, Circulation.

[35]  C. Boring,et al.  Cancer statistics, 1990 , 1990, CA: a cancer journal for clinicians.

[36]  N. Sakalihasan,et al.  Modifications of the extracellular matrix of aneurysmal abdominal aortas as a function of their size. , 1993, European journal of vascular surgery.

[37]  T. Länne,et al.  Reduced aortic wall stress in diabetes mellitus. , 2007, European journal of vascular and endovascular surgery : the official journal of the European Society for Vascular Surgery.

[38]  N. Turner,et al.  Inherent differences in morphology, proliferation, and migration in saphenous vein smooth muscle cells cultured from nondiabetic and Type 2 diabetic patients. , 2009, American journal of physiology. Cell physiology.

[39]  G. Moneta,et al.  The aneurysm detection and management study screening program: validation cohort and final results. Aneurysm Detection and Management Veterans Affairs Cooperative Study Investigators. , 2000, Archives of internal medicine.

[40]  Per Eriksson,et al.  Influence of intraluminal thrombus on structural and cellular composition of abdominal aortic aneurysm wall. , 2003, Journal of vascular surgery.

[41]  F. Folli,et al.  A combination of PPAR-gamma agonists and HMG CoA reductase inhibitors (statins) as a new therapy for the conservative treatment of AAS (aortic aneurysm syndromes). , 2009, Medical hypotheses.

[42]  F. Howe,et al.  Rosiglitazone Reduces the Development and Rupture of Experimental Aortic Aneurysms , 2009, Circulation.

[43]  P. Eriksson,et al.  The Intraluminal Thrombus as a Source of Proteolytic Activity , 2006, Annals of the New York Academy of Sciences.

[44]  J. Skyler,et al.  Diabetes trends in the USA , 2002, Diabetes/metabolism research and reviews.

[45]  H. Bilo,et al.  Prevalence, incidence and mortality of type 2 diabetes mellitus revisited: A prospective population-based study in The Netherlands (ZODIAC-1) , 2002, European Journal of Epidemiology.

[46]  E F Bernstein,et al.  Computed tomography scanning findings associated with rapid expansion of abdominal aortic aneurysms. , 1994, Journal of vascular surgery.

[47]  B. Kingwell,et al.  Ramipril Reduces Large-Artery Stiffness in Peripheral Arterial Disease and Promotes Elastogenic Remodeling in Cell Culture , 2005, Hypertension.

[48]  M. Ihnat,et al.  Clinical review 2: The "metabolic memory": is more than just tight glucose control necessary to prevent diabetic complications? , 2009, The Journal of clinical endocrinology and metabolism.

[49]  D. Bergqvist,et al.  Increasing prevalence of abdominal aortic aneurysms. A necropsy study. , 1992, The European journal of surgery = Acta chirurgica.

[50]  H. Armenian,et al.  Risk factors for abdominal aortic aneurysm: results of a case-control study. , 2000, American journal of epidemiology.

[51]  D A Vorp,et al.  Association of intraluminal thrombus in abdominal aortic aneurysm with local hypoxia and wall weakening. , 2001, Journal of vascular surgery.

[52]  N. Wiernsperger,et al.  Signaling pathways involved in human vascular smooth muscle cell proliferation and matrix metalloproteinase-2 expression induced by leptin: inhibitory effect of metformin. , 2005, Diabetes.

[53]  M I Patel,et al.  Current views on the pathogenesis of abdominal aortic aneurysms. , 1995, Journal of the American College of Surgeons.

[54]  D J Ballard,et al.  Prevalence and Associations of Abdominal Aortic Aneurysm Detected through Screening , 1997, Annals of Internal Medicine.

[55]  T. Sørensen,et al.  The changing lifestyle in the world. Body weight and what else? , 2000, Diabetes care.

[56]  A. Ergul,et al.  Evidence for a matrix metalloproteinase induction/activation system in arterial vasculature and decreased synthesis and activity in diabetes. , 2002, Diabetes.

[57]  M. Halak,et al.  Abdominal aortic aneurysm and aortic occlusive disease: a comparison of risk factors and inflammatory response. , 2000, European journal of vascular and endovascular surgery : the official journal of the European Society for Vascular Surgery.

[58]  W. Pearce,et al.  Size matters: the relationship between MMP-9 expression and aortic diameter. , 1997, Circulation.

[59]  J. Golledge,et al.  Serum carboxymethyllysine concentrations are reduced in diabetic men with abdominal aortic aneurysms: Health In Men Study. , 2009, Journal of vascular surgery.

[60]  M. Gacko,et al.  Metalloproteinases, insulin‐like growth factor‐I and its binding proteins in aortic aneurysm , 2004, International journal of experimental pathology.

[61]  W. Pearce,et al.  Abdominal Aortic Aneurysm as a Complex Multifactorial Disease , 2006, Annals of the New York Academy of Sciences.

[62]  A. V. Rij,et al.  Association of the 4G/5G polymorphism in the promoter region of plasminogen activator inhibitor-1 with abdominal aortic aneurysms. , 2000, Journal of vascular surgery.

[63]  S. Fisher,et al.  Higher prevalence of abdominal aortic aneurysms in patients with carotid stenosis but without diabetes. , 1999, Surgery.

[64]  J. Powell,et al.  Inflammation and matrix metalloproteinases in the enlarging abdominal aortic aneurysm. , 1995, Arteriosclerosis, thrombosis, and vascular biology.